ABSTRACT Responses of smooth muscle to kallikreins (EC 3.4.21.8) are generally considered to result from idnin formation. This premise was reexamined with the isolated rat uterus. Rat urinary kallikrein or bradykinin produced dose-dependent contractions of rat uterus but kallikrein was 5-fold more potent than bradykdnin. Kallikrein caused an immediate series of rythmic contractions which could be increased gradually with subsequent addition of kininogen substrate. Kallikrein-induced contractions were unaffected by carboxypeptidase B or a bradykinin antiserum whereas bradykinin-induced contractions were attenuated or abolished. Other serine proteinases, including trypsin, either did not induce contraction in the absence of added kininogen or did so minimally. Although small amounts of kininogen-like substrate were found in uterine tissue, detectable kinin levels (>4 pg) could not be found in bathing media during maximal kallikrein-induced contractions or after uterine tissue was incubated with high concentrations of the enzyme in the presence of SQ 20881, a kdninase II inhibitor. The data suggest that-uterine contraction produced by a homologous kallikrein does not involve kinin formation but results from an action of this serine proteinase upon other accessible systems coupled to the contractile response.
Glandular kallikrein (EC 3.4.21.8) liberates lysylbradykinin (kallidin) from kininogen substrates by limited proteolysis. Although this serine proteinase can attack proinsulin or prorenin in vitro (1, 2) , responses of smooth muscle to this kallikrein are attributed to kinin formation and a subsequent peptide-receptor interaction (3) (4) (5) . However, -Beraldo (6, 7) reported that rat glandular kallikrein produced rat uterine contractions in the absence of added kininogen or after pretreatment with actinomycin D or puromycin. It was suggested, but not shown, that these agents might have inhibited endogenous kininogen synthesis, and thus the effects of kallikrein were "direct." Conversely, the uterine contractile response to glandular kallikrein was suggested to depend on a detected kininogen substrate in the tissue (8, 9) .
In the present study we have found that rat glandular kallikrein can cause contraction ofthe rat uterus without detectable kinin liberation.
MATERIALS AND METHODS
Materials. Rat urinary kallikrein B was purified to homogeneity with ammonium sulfate fractionation and chromatography on DEAE-cellulose, CM-cellulose, and Sephadex G-100. "Vertical slab" polyacrylamide gel electrophoresis produced a single band after Coomassie blue staining. The preparation was also homogeneous when analyzed by polyacrylamide isoelectric focusing (10) . An antiserum to pure kallikrein B was raised in a sheep (10) . Human urinary kallikrein was purified to homogeneity with a modification of the scheme described for rat urinary kallikrein and with aprotinin-agarose affinity chromatography as described (11 Diniz and Carvalho (16) . Rat uterine horns were removed, freed offat, weighed, minced, and homogenized in 10 ml oficecold Tyrode's solution with an all-glass conical homogenizer and subsequently with a Polytron PT ST (Brinkmann) for 15 sec at maximum setting. The homogenates (10 ml) were treated with 0.5% deoxycholate for 30 min at room temperature and then centrifuged at 20,000 x g for 30 min. The supernatant was then desalted through Sephadex G-25 via centrifugation (17) . Protein concentration was measured by the procedure of Lowry et aL (18) with bovine serum albumin as the standard.
Uterine extracts were divided into three groups: untreated, heat-treated (600C, 60 min), and boiled (100TC, 10 min). A sample (0.2 ml) of each extract was added to 0.2 ml of 0.1 M phosphate, pH 8.5/30 mM sodium EDTA/3 mM 1,10-phenanthroline plus 0.05 ml of trypsin (0.9 MM), rat urinary kallikrein (30 nM), human urinary kallikrein (5 nM), rat urinary esterase A (30 nM), or H20; the final volume was made 0.5 ml. Reaction mixtures without uterine homogenates or enzymes were used as blanks. After incubation at 37C for 60 min, reactions were stopped by boiling for 20 min. Kininogen was measured by radioimmunoassay ofgenerated kinins (14) with bradykinin as the standard. In addition, any in situ kinin-generating activity of 6154 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
kallikreins was measured by kinin radioimmunoassay of bath media during contractile responses or after uterine strips were incubated with supramaximal enzyme concentrations in the presence of kininase II inhibition (SQ 20881, 100 tg/ml).
RESULTS
The typical and prompt dose-dependent contractile responses of the rat uterus to kallikrein or bradykinin are shown in Fig.  1 (Upper). The cumulative dose-response curves to kallikrein and bradykinin at concentrations ranging from 9 .0 x 10-11 to 1.4 X 10-8 M. Calculated molar concentrations of kallikrein required to produce 1.0-and 1.5-g increases in contractile force were one-fourth and one-sixth the concentrations ofbradykinin required to produce equivalent responses.
Kallikrein typically produced rapid and rhythmic contractions followed by spontaneous and full relaxation (Fig. 2) . Sub Preimmune serum had no effect on uterine contractions produced by either bradykinin or kallikrein. Kallikrein-induced contractions were not affected by bradykinin antiserum added to the organ bath, but bradykinin-induced contractions were significantly reduced (Fig. 4) . Bradykinin responses were restored after removal of antiserum.
Responses to other serine proteinases known to liberate kinins from kininogen substrates were studied. Human urinary kallikrein (11), rat urinary esterase A (12) , and trypsin produced the typical uterine contractions when kininogen was preincu- (14) . Untreated, heat-treated (600C, 60 min), or boiled (10 min) uterine homogenates were treated with typsin (0.9 tiM). Mean (± SEM) kininogen content, in terms of the released kinin measured by radioimmunoassay, was 29.3 ± 1.9, 30.7 ± 0.3, and 26.5 ± 0.7 ng of kinin equivalents/mg protein in untreated, heat-treated, or boiled homogenates, respectively (n = 4). Ex It is known that other rat glandular kallikreins (e.g., pancreatic and salivary) cause the isolated rat uterus to contract (20, 21) ; these enzymes have been considered to be 500-fold more potent than trypsin insofar as this effect is concerned (22) . However, because small but detectable quantities of a kinin-releasing substrate have been found within the organ (23) , the mechanism of kallikrein-induced uterine contraction has been uncertain. The possibility exists that this detectable kininogen is residual from plasma which contains 3-10 Zg of bradykinin equivalents/ml. On the other hand, the possibility exists that rat glandular kallikrein uniquely releases kinin from some endogenous uterine kininogen to a location not accessible to available kinin antibody or kininase and in quantities too small to be detected by radioimmunoassay. This seems unlikely because the efficiency of trypsin as a kdninogenase is not paralleled by contractile efficacy.
Proc. Natd Acad. Sci. USA 78 (1981) 6157 Fiedler (24) has pointed out that, although kallikreins are defined by one function (i.e., the ability to liberate a kinin from kininogen), definite proof that this is the only role of these enzymes is lacking. This is especially pertinent because activities of these serine proteinases not related to kinin are now being discovered. Thus, the abilities ofplasma or glandular kallikreins to cleave proinsulin (1), activate prorenin (2), release renin (25) , attack angiotensinogen (26) , and, now, contract the uterus suggest that the enzymes have other important biologic functions.
It is now known that glandular kallikrein exists in rat plasma (27) . Aprotinin, an effective inhibitor ofglandular kallikrein, has been found to decrease pregnant uterine muscular activity and prolong the duration of parturition (28) . Whether the enzyme has some role in parturition-for example, via the adenyl cyclase activation that occurs in response to various serine proteinases in the rat ovary (29)-remains to be determined.
